Sample Size Reestimation: A Review and Recommendations

Despite best efforts, some crucial information used to design a confirmatory trial may not be available, or may be available but with a high degree of uncertainty, at the design stage. When this happens, it may be prudent to check the validity of those assumptions using interim data from the study and make midcourse adjustment if necessary. One such adjustment is to modify the sample size. In this article, we focus on sample size reestimation (SSR) for phase III and IV studies. The discussion is relevant to both continuous and binary endpoints even though the basis for SSR might differ for those two cases. We review commonly used approaches to adjust sample size and provide recommendations on how SSR should be implemented to achieve the objectives and maintain the integrity of the trial. The recommendations cover scientific, procedural, and logistic considerations.

[1]  Donald A. Berry,et al.  Statistical Innovations in Cancer Research , 2003 .

[2]  Yuliya Lokhnygina Topics in design and analysis of clinical trials. , 2004 .

[3]  T. Friede,et al.  A comparison of methods for adaptive sample size adjustment , 2001, Statistics in medicine.

[4]  A. Gould Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.

[5]  Cyrus R Mehta,et al.  Adaptive, group sequential and decision theoretic approaches to sample size determination , 2006, Statistics in medicine.

[6]  D. Siegmund Sequential Analysis: Tests and Confidence Intervals , 1985 .

[7]  A. Tsiatis,et al.  On the inefficiency of the adaptive design for monitoring clinical trials , 2003 .

[8]  R. Muirhead,et al.  Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America , 2007 .

[9]  P. Bauer,et al.  The reassessment of trial perspectives from interim data—a critical view , 2006, Statistics in medicine.

[10]  C. Burman,et al.  Are Flexible Designs Sound? , 2006, Biometrics.

[11]  T. Friede,et al.  Sample size recalculation for binary data in internal pilot study designs , 2004 .

[12]  M. Krams,et al.  Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group , 2006, Journal of biopharmaceutical statistics.

[13]  Alex Dmitrienko,et al.  Analysis of Clinical Trials Using SAS: A Practical Guide , 2005 .

[14]  Michael A Proschan,et al.  Two-Stage Sample Size Re-Estimation Based on a Nuisance Parameter: A Review , 2005, Journal of biopharmaceutical statistics.

[15]  Christopher Jennison,et al.  Are flexible designs sound? Discussion , 2006 .

[16]  Meinhard Kieser,et al.  Simple procedures for blinded sample size adjustment that do not affect the type I error rate , 2003, Statistics in medicine.

[17]  W. Lehmacher,et al.  Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.

[18]  Sue-Jane Wang,et al.  Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.

[19]  Alan Y. Chiang,et al.  Data Analysis of Asymmetric Structures: Advanced Approaches in Computational Statistics , 2006, Technometrics.

[20]  Christopher Jennison,et al.  Mid‐course sample size modification in clinical trials based on the observed treatment effect , 2002, Statistics in medicine.

[21]  Anastasios A Tsiatis,et al.  Adaptive two‐stage designs in phase II clinical trials , 2006, Statistics in medicine.

[22]  Anastasios A. Tsiatis,et al.  Flexible Sample Size Considerations Using Information-Based Interim Monitoring , 2001 .

[23]  Christopher Jennison,et al.  Efficient group sequential designs when there are several effect sizes under consideration , 2006, Statistics in medicine.

[24]  M A Proschan,et al.  Designed extension of studies based on conditional power. , 1995, Biometrics.

[25]  B. Turnbull,et al.  Group Sequential Methods , 1999 .

[26]  Martin Posch,et al.  Issues in designing flexible trials , 2003, Statistics in medicine.

[27]  M. Proschan,et al.  Designed extension of studies based on conditional power. , 1995 .

[28]  A L Gould,et al.  Sample size re‐estimation: recent developments and practical considerations , 2001, Statistics in medicine.

[29]  Christopher Jennison,et al.  Adaptive and nonadaptive group sequential tests , 2006 .

[30]  G. Chi,et al.  On Sample Size and Inference for Two‐Stage Adaptive Designs , 2001, Biometrics.

[31]  W. Shih Sample size re‐estimation – journey for a decade , 2001, Statistics in medicine.